The Supreme Court has declared that the human genome cannot be patented, at least as it occurs in nature.

In what might be something of the Court trying to find a middle ground, justices did say something they create out of gene isolation could be patented making it a win for Myriad genetics – one of the players in this case – because they created a synthetic form of the genes.

Host Carmen Russell-Sluchansky spoke with Andrew Torrance, a law professor at the University of Kansas, and Dr. Caleph Wilson, of the Translation Research Unit and the Department of Microbiology at the University of Pennsylvania, to discuss the story.